Windtree Therapeutics, Inc.
WINT
$1.30
$0.075.69%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 2.77M | 1.59M | 2.15M | 1.41M | 2.58M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.74M | 11.45M | 4.41M | 4.26M | 4.69M |
| Operating Income | -4.74M | -11.45M | -4.41M | -4.26M | -4.69M |
| Income Before Tax | -2.99M | -11.83M | 10.33M | -5.15M | -4.43M |
| Income Tax Expenses | -240.00K | 197.00K | 114.00K | -- | -- |
| Earnings from Continuing Operations | -2.75M | -12.02M | 10.22M | -5.15M | -4.43M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.75M | -12.02M | 10.22M | -5.15M | -4.43M |
| EBIT | -4.74M | -11.45M | -4.41M | -4.26M | -4.69M |
| EBITDA | -4.69M | -11.37M | -4.38M | -4.24M | -4.68M |
| EPS Basic | -211.39 | -1.05K | -- | -- | -- |
| Normalized Basic EPS | -107.81 | -642.77 | -- | -- | -- |
| EPS Diluted | -211.39 | -1.05K | -- | -- | -- |
| Normalized Diluted EPS | -107.81 | -642.77 | -- | -- | -- |
| Average Basic Shares Outstanding | 17.70K | 11.50K | -- | -- | -- |
| Average Diluted Shares Outstanding | 17.70K | 11.50K | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -12.62% | -- | -- | -- | -- |
